The NC Diabetes Research Center (UNC, Duke, Wake Forest University and N.C. A&T) is holding its second annual Research Symposium at N.C. A&T on Friday, March 15th, from 9:00am to 1:30pm.

View the full agenda and REGISTER.

Location: N.C. A&T State University - Union Square Campus (Greensboro, NC)

Featuring: Louis Philipson, MD, PhD
Dr. Philipson serves as President-elect, Medicine and Science for the American Diabetes Association (ADA) in 2018. He is Director of the Kovler Diabetes Center, and was recently named as the James C. Tyree Professor of Diabetes Research and Care in the Departments of Medicine and Pediatrics at the University of Chicago. A diabetologist and translational scientist with interests in beta cell biology, biophysics and genetics of diabetes, Dr. Philipson was part of the team that discovered insulin gene mutations causing neonatal diabetes, a novel class of mutations causing diabetes through beta-cell ER stress.

Dr. Philipson, together with his colleagues Drs. Graeme Bell, Siri Atma Greeley and Rochelle Naylor, established the leading United States registry for monogenic diabetes including neonatal diabetes and Mature Onset Diabetes of the Young (MODY). Dr. Philipson was named one of America’s Top Doctors by U.S. News and World Report magazine, and Chicago Magazine named him a Top Doctor in Endocrinology, Diabetes and Metabolism. His extensive body of work includes more than 180 peer-reviewed publications including letters, reviews, perspectives and chapters. He was recently named a recipient of the 2018 Order of Lincoln Award, which honors public service for the betterment of humanity in Illinois, the state’s highest civilian honor.

Additionally, the NC Diabetes Research Center is announcing its second annual call for cross-institutional pilot awards. This is a great opportunity for your faculty members who may be considering a new project related to diabetes.

Purpose: This pilot program is designed to encourage and facilitate novel basic, clinical, and translational research. Projects must demonstrate a clear path to subsequent grant support, new company formation, licensing, not-for-profit partnering, or other channels. Projects must have a clear diabetes focus and involve co-Principal Investigators at a minimum of two of the four institutions. Additional priority will be made for proposals that make use of certain core facilities outlined in the RFA.

Deadline: Letter of Intent: April 1, 2019. Full Application Invitation: April 15, 2019. Full Application Due: May 13, 2019.

Funding information: The research activities at each participating institution will be funded by that institution. Each institution will contribute up to $25,000 in direct costs, with a limit of a total of up to $100,000 per collaborative project if all 4 institutions are involved. The budget period is for 12 months beginning between July 1, 2019 and ending no later than June 30, 2020.

The Submission Portal for the NC Diabetes Research Collaborative Pilot Grant: Letter of Intent can be accessed here.

NC TraCS Institute logo vertical

In partnership with:

Contact Us

Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

This email address is being protected from spambots. You need JavaScript enabled to view it.


Cite Us

CitE and SUBMit CTSA Grant number - UL1TR002489

© 2008-2021 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact